{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:03:34Z","timestamp":1782180214471,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Long-term cost-effectiveness analyses of health behaviour interventions to effectively manage type 2 diabetes mellitus (T2DM) in low-income countries are crucial for minimising economic burden and optimising resource allocation. Therefore, this study aimed to estimate the long-term cost-effectiveness of implementing a health behaviour intervention to manage T2DM in Nepal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A Markov model in combination with a decision tree was developed to compare the costs and outcomes of the health behaviour intervention against usual care among 481 (238-intervention and 243-control) participants from healthcare system\u00a0and societal perspectives. The model integrates empirical trial data, with published data to inform parameters not collected during the trial. The model estimated costs, quality-adjusted life years (QALYs) and cost-effectiveness over 5\u00a0years, 10\u00a0years, 20\u00a0years, 30\u00a0years and a lifetime time\u00a0horizons with 3% annual discounting. Sub-group, scenarios, both one-way and two-way analyses and probabilistic sensitivity analyses (PSA) were performed to assess the impact of uncertainty in the model under the threshold of 3 times gross domestic product (GDP) per capita (i.e., US $4140) for Nepal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Base-case analysis with lifetime horizon showed that the health behaviour intervention compared to usual care improved QALYs by 3.88 and increased costs by US $4293 per patient, with an incremental cost-effectiveness ratio (ICER) of US $1106 per QALY gained from a healthcare system\u00a0perspective. From a societal perspective, QALYs also improved by 3.88 and costs increased by US $4550, with an ICER of US $1173 per QALY gained. Furthermore, the intervention demonstrated ICERs of US $636, US $678, US $637, and US $632 per QALY gained over 5-, 10-, 20-, and 30-year time horizons, respectively, from a healthcare system\u00a0perspective, and US $719, US $766, US $659, and US $716 per QALY gained from a societal perspective<jats:italic>.<\/jats:italic> In the PSA, the probability of the health behaviour intervention being cost-effective was over 57%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The health behaviour intervention for managing T2DM was cost-effective over a lifetime horizon compared to usual care. To maximise its impact, this intervention should be scaled up nationwide, and future research is warranted to assess the long-term cost-effectiveness across diverse settings in low-income countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Australia and New Zealand Clinical Trial Registry (ACTRN12621000531819).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-03981-8","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:15:49Z","timestamp":1741698949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5978-3762","authenticated-orcid":false,"given":"Padam Kanta","family":"Dahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneel","family":"Vandelanotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lal","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidul Alam","family":"Mahumud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grish","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeji","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biraj","family":"Karmacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Sugishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanfina","family":"Ademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"3981_CR1","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334."},{"key":"3981_CR2","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 10th Edition. Brussels, Belgium: International Diabetes Federation; 2021 2021."},{"issue":"4","key":"3981_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/heapol\/czy011","volume":"33","author":"N Ide","year":"2018","unstructured":"Ide N, LoGerfo JP, Karmacharya B. Barriers and facilitators of diabetes services in Nepal: a qualitative evaluation. Health Policy Plan. 2018;33(4):474\u201382.","journal-title":"Health Policy Plan"},{"key":"3981_CR4","doi-asserted-by":"crossref","unstructured":"Jacobs-Van Der Bruggen MAM, Bos GT, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA. Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk. Diabetes Care. 2007;30(1):128\u201334.","DOI":"10.2337\/dc06-0690"},{"issue":"1","key":"3981_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-7547-9-17","volume":"9","author":"A Neumann","year":"2011","unstructured":"Neumann A, Schwarz P, Lindholm L. Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling. Cost Eff Resour Alloc. 2011;9(1):17.","journal-title":"Cost Eff Resour Alloc"},{"issue":"6","key":"3981_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.7326\/M15-0469","volume":"163","author":"R Li","year":"2015","unstructured":"Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, et al. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):452\u201360.","journal-title":"Ann Intern Med"},{"issue":"7","key":"3981_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14847","volume":"39","author":"J Park","year":"2022","unstructured":"Park J, Zhang P, Shao H, Laxy M, Imperatore G. Selecting a target population for type 2 diabetes lifestyle prevention programs: A cost-effectiveness perspective. Diabet Med. 2022;39(7): e14847.","journal-title":"Diabet Med"},{"issue":"7","key":"3981_CR8","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2337\/dci20-0017","volume":"43","author":"KR Siegel","year":"2020","unstructured":"Siegel KR, Ali MK, Zhou X, Ng BP, Jawanda S, Proia K, et al. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? Diabetes Care. 2020;43(7):1557\u201392.","journal-title":"Diabetes Care"},{"issue":"12","key":"3981_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242962","volume":"15","author":"W Hu","year":"2020","unstructured":"Hu W, Xu W, Si L, Wang C, Jiang Q, Wang L, et al. Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study. PLoS ONE. 2020;15(12): e0242962.","journal-title":"PLoS ONE"},{"key":"3981_CR10","doi-asserted-by":"crossref","unstructured":"A Nationwide Community-Based Lifestyle Program Could Delay Or Prevent Type 2 Diabetes Cases And Save $5.7\u00a0Billion In 25\u00a0Years. Health Affairs. 2012;31(1):50\u201360.","DOI":"10.1377\/hlthaff.2011.1115"},{"issue":"7","key":"3981_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci20-0018","volume":"43","author":"X Zhou","year":"2020","unstructured":"Zhou X, Siegel KR, Ng BP, Jawanda S, Proia KK, Zhang X, et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care. 2020;43(7):1593\u2013616.","journal-title":"Diabetes Care"},{"issue":"8","key":"3981_CR12","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2337\/dc10-0843","volume":"33","author":"R Li","year":"2010","unstructured":"Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review. Diabetes Care. 2010;33(8):1872\u201394.","journal-title":"Diabetes Care"},{"issue":"17","key":"3981_CR13","doi-asserted-by":"publisher","first-page":"10799","DOI":"10.3390\/ijerph191710799","volume":"19","author":"PK Dahal","year":"2022","unstructured":"Dahal PK, Rawal LB, Mahumud RA, Paudel G, Sugishita T, Vandelanotte C. Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials. Int J Environ Res Public Health. 2022;19(17):10799.","journal-title":"Int J Environ Res Public Health"},{"key":"3981_CR14","doi-asserted-by":"publisher","first-page":"4701796","DOI":"10.1155\/2022\/4701796","volume":"2022","author":"AR Pandey","year":"2022","unstructured":"Pandey AR, Aryal KK, Shrestha N, Sharma D, Maskey J, Dhimal M. Burden of Diabetes Mellitus in Nepal: An Analysis of Global Burden of Disease Study 2019. J Diabetes Res. 2022;2022:4701796.","journal-title":"J Diabetes Res"},{"issue":"9","key":"3981_CR15","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s13300-020-00884-0","volume":"11","author":"N Shrestha","year":"2020","unstructured":"Shrestha N, Mishra SR, Ghimire S, Gyawali B, Mehata S. Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis. Diabetes Ther. 2020;11(9):1935\u201346.","journal-title":"Diabetes Ther"},{"key":"3981_CR16","doi-asserted-by":"crossref","unstructured":"Rasmita S, Aditya S and Sapkota VP. Health expenditure among the outpatient of type-2 diabetes in selected hospital of Kathmandu district: A cross sectional study. Adv Public Health. 2024;2024(1):5571393.","DOI":"10.1155\/2024\/5571393"},{"issue":"190","key":"3981_CR17","first-page":"343","volume":"52","author":"N Shrestha","year":"2013","unstructured":"Shrestha N, Lohani SP, Angdembe MR, Bhattarai K, Bhattarai J. Cost of diabetes mellitus care among patients attending selected outpatient clinics. JNMA J Nepal Med Assoc. 2013;52(190):343\u20138.","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"1","key":"3981_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s13063-023-07451-5","volume":"24","author":"L Rawal","year":"2023","unstructured":"Rawal L, Dahal P, Paudel G, Biswas T, Shrestha R, Makaju D, et al. Community-based lifestyle intervention for diabetes (Co-LID study) management in rural Nepal: study protocol for a clustered randomized controlled trial. Trials. 2023;24(1):441.","journal-title":"Trials"},{"issue":"1","key":"3981_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Value Health. 2022;25(1):3\u20139.","journal-title":"Value Health"},{"issue":"1","key":"3981_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00019053-200725010-00002","volume":"25","author":"RL Fleurence","year":"2007","unstructured":"Fleurence RL, Hollenbeak CS. Rates and probabilities in economic modelling: transformation, translation and appropriate application. Pharmacoeconomics. 2007;25(1):3\u20136.","journal-title":"Pharmacoeconomics"},{"key":"3981_CR21","doi-asserted-by":"crossref","unstructured":"Briggs AH, Claxton K, Sculpher MJ. Decision Modelling for Health Economic Evaluation: Oxford University Press; 2006.","DOI":"10.1093\/oso\/9780198526629.001.0001"},{"key":"3981_CR22","doi-asserted-by":"crossref","unstructured":"Shrestha DB, Budhathoki P, Sedhai YR, Marahatta A, Lamichhane S, Nepal S, et al. Type 2\u00a0Diabetes\u00a0Mellitus in\u00a0Nepal\u00a0from 2000 to 2020: A systematic review and meta-analysis. F1000Res. 2021;10:543.","DOI":"10.12688\/f1000research.53970.1"},{"issue":"1","key":"3981_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13643-021-01619-3","volume":"10","author":"T Shirvani","year":"2021","unstructured":"Shirvani T, Javadivala Z, Azimi S, Shaghaghi A, Fathifar Z, Devender Bhalla HDR, et al. Community-based educational interventions for prevention of type II diabetes: a global systematic review and meta-analysis. Syst Rev. 2021;10(1):81.","journal-title":"Syst Rev"},{"issue":"8","key":"3981_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1001\/jama.2021.10403","volume":"326","author":"DE Jonas","year":"2021","unstructured":"Jonas DE, Crotty K, Yun JDY, Middleton JC, Feltner C, Taylor-Phillips S, et al. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;326(8):744\u201360.","journal-title":"JAMA"},{"issue":"5","key":"3981_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pcd.2018.07.003","volume":"12","author":"A Glechner","year":"2018","unstructured":"Glechner A, Keuchel L, Affengruber L, Titscher V, Sommer I, Matyas N, et al. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Prim Care Diabetes. 2018;12(5):393\u2013408.","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"3981_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s41256-024-00364-z","volume":"9","author":"PK Dahal","year":"2024","unstructured":"Dahal PK, Ademi Z, Rawal L, Mahumud RA, Paudel G, Karmacharya B, et al. Health economic evaluation alongside randomised clinical trial of a health behaviour intervention to manage type 2 diabetes in Nepal. Global Health Research and Policy. 2024;9(1):52.","journal-title":"Global Health Research and Policy"},{"key":"3981_CR27","unstructured":"World Health Organisation. Life table by country Nepal. https:\/\/apps.who.int\/gho\/data\/view.main.LT62120?lang=en (2020). Assessed 26 Oct 2023."},{"key":"3981_CR28","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.3402\/gha.v9.31704","volume":"9","author":"B Gyawali","year":"2016","unstructured":"Gyawali B, Ferrario A, van Teijlingen E, Kallestrup P. Challenges in diabetes mellitus type 2 management in Nepal: a literature review. Glob Health Action. 2016;9:31704.","journal-title":"Glob Health Action"},{"issue":"6","key":"3981_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002575","volume":"15","author":"KR Thankappan","year":"2018","unstructured":"Thankappan KR, Sathish T, Tapp RJ, Shaw JE, Lotfaliany M, Wolfe R, et al. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program. PLoS Med. 2018;15(6): e1002575.","journal-title":"PLoS Med"},{"key":"3981_CR30","doi-asserted-by":"crossref","unstructured":"Dahal PK, Rawal L, Ademi Z, Mahumud RA, Paudel G, Vandelanotte C. Estimating the Health Care Expenditure to Manage and Care for Type 2 Diabetes in Nepal: A Patient Perspective. MDM Policy & Practice. 2023;8(2).","DOI":"10.1177\/23814683231216938"},{"key":"3981_CR31","unstructured":"The World Bank. Official exchange rate (LCU per US$, peroid average). https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF?end=2022&start=1960&view=chart (2023). Assessed 12 Febuary 2023."},{"issue":"2","key":"3981_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017;15(2):127\u201337.","journal-title":"Appl Health Econ Health Policy"},{"key":"3981_CR33","unstructured":"EuroQol. Reverse Cross Walk V2.2. https:\/\/euroqol.org\/wp-content\/uploads\/2020\/11\/Reverse-cross-walk-V2.2.xls (2020). Assessed 26 January 2023."},{"issue":"7","key":"3981_CR34","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jval.2021.11.1370","volume":"25","author":"G Jyani","year":"2022","unstructured":"Jyani G, Sharma A, Prinja S, Kar SS, Trivedi M, Patro BK, et al. Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set. Value in Health. 2022;25(7):1218\u201326.","journal-title":"Value in Health"},{"key":"3981_CR35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/B978-0-323-05796-7.00042-4","volume-title":"Clinical Nuclear Cardiology","author":"LJ Shaw","year":"2010","unstructured":"Shaw LJ. Chapter 24 - Cost-Effectiveness of Myocardial Perfusion Single-Photon Emission Computed Tomography. In: Zaret BL, Beller GA, editors. Clinical Nuclear Cardiology. 4th ed. Philadelphia: Mosby; 2010. p. 400\u201312.","edition":"4"},{"key":"3981_CR36","unstructured":"International Monetary Fund. GDP per capita, current prices https:\/\/www.imf.org\/external\/datamapper\/NGDPDPC@WEO\/NPL?zoom=NPL&highlight=NPL (2023). Assessed 14 August 2023."},{"issue":"12","key":"3981_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2471\/BLT.15.164418","volume":"94","author":"MY Bertram","year":"2016","unstructured":"Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94(12):925\u201330.","journal-title":"Bull World Health Organ"},{"key":"3981_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1017\/gmh.2022.54","volume":"9","author":"LR Aldridge","year":"2022","unstructured":"Aldridge LR, Luitel NP, Jordans MJD, Bass JK, Patenaude B. Cost-effectiveness of psychological intervention within services for depression delivered by primary care workers in Nepal: economic evaluation of a randomized control trial. Glob Ment Health (Camb). 2022;9:499\u2013507.","journal-title":"Glob Ment Health (Camb)"},{"issue":"4","key":"3981_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40273-015-0327-2","volume":"34","author":"P Vemer","year":"2016","unstructured":"Vemer P, Corro Ramos I, van Voorn GA, Al MJ, Feenstra TL. AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. Pharmacoeconomics. 2016;34(4):349\u201361.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"3981_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-7547-9-17","volume":"9","author":"A Neumann","year":"2011","unstructured":"Neumann A, Schwarz P, Lindholm L. Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling. Cost Effectiveness and Resource Allocation. 2011;9(1):17.","journal-title":"Cost Effectiveness and Resource Allocation"},{"issue":"9","key":"3981_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s10157-023-02357-7","volume":"27","author":"Y Suzuki","year":"2023","unstructured":"Suzuki Y, Hoshi K, Shiroiwa T, Fukuda T. Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes. Clin Exp Nephrol. 2023;27(9):728\u201336.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"3981_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10198-016-0851-9","volume":"18","author":"A Neumann","year":"2017","unstructured":"Neumann A, Lindholm L, Norberg M, Schoffer O, Klug SJ, Norstr\u00f6m F. The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program. Eur J Health Econ. 2017;18(7):905\u201319.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"3981_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/dom.13485","volume":"21","author":"J Lian","year":"2019","unstructured":"Lian J, McGhee SM, So C, Chau J, Wong CKH, Wong WCW, et al. Long-term cost-effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care. Diabetes Obes Metab. 2019;21(1):73\u201383.","journal-title":"Diabetes Obes Metab"},{"key":"3981_CR44","first-page":"1","volume":"2020","author":"J Ma","year":"2020","unstructured":"Ma J, Wan X, Wu B. The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting. J Diabetes Res. 2020;2020:1\u20138.","journal-title":"J Diabetes Res"},{"issue":"6","key":"3981_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.7326\/M15-0469","volume":"163","author":"R Li","year":"2015","unstructured":"Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, et al. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):452\u201360.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3981_CR46","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2337\/dc10-0843","volume":"33","author":"R Li","year":"2010","unstructured":"Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872\u201394.","journal-title":"Diabetes Care"},{"key":"3981_CR47","doi-asserted-by":"crossref","unstructured":"Dahal PK, Rawal LB, Mahumud RA, Paudel G, Sugishita T, Vandelanotte C. Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials. Int J Environ Res Public Health. 2022;19(17).","DOI":"10.3390\/ijerph191710799"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03981-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03981-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03981-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:15:58Z","timestamp":1741698958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03981-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03981-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval for this study was obtained from the Human Research Ethics Committee (HRECs) of Nepal Health Research Council, Nepal (#944\/2019P); Tokyo Women\u2019s Medical University, Japan (IRC-approval 200801); Kathmandu University, Nepal (IRC-KUMS 26\/20); and Central Queensland University, Australia (CQU RSH\/HE 0000022453). This intervention was registered in the Australia and New Zealand Clinical Trial Registry (ANZCTR) (ACTRN12621000531819).All participants provide their informed consent prior to participation. The privacy and confidentiality of each participant\u2019s information gathered and disseminated throughout the data collection process was strictly maintained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"153"}}